Cuprina Holdings (cayman) LTD is a US-listed company in the health care equipment industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
Not valued: the figures our models need are missing or failed our data-quality checks.
No model value: free cash flow after stock pay is not positive. How we value companies.
Cuprina Holdings (cayman) LTD valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Cuprina has little or no product revenue yet; it used $7m of cash in the twelve months. The diluted share count is up 13.7% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 4 of our 6 financial-health checks.
Our models give no value for Cuprina Holdings (cayman) at present, so past values are not shown.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Cuprina Holdings (cayman) LTD's trailing-twelve-month revenue grew 5.6% year on year, with a free-cash-flow margin of -18423.4%. Where it stands out: change in growth rate of +57.4pp ranks 3 of 129 health care equipment companies we cover. Where it lags: free-cash-flow margin of -18423.4% ranks 128 of 128 health care equipment companies we cover.
Current signal Free cash flow diverging from earnings: TTM free cash flow fell 647.6% while net income fell 206.4%: a 441pp divergence.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for CUPR from the sources we follow. See filings →
We value Cuprina Holdings (cayman) LTD as an operating company, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: no positive earnings in the latest twelve months |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: the model gives no positive value |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: return on equity is not positive |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | — 0 | Does not apply: no positive value |
| Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | — | No model applies: the filings don’t yet support a value. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Cuprina Holdings (cayman) LTD with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
No analyst estimates are published for Cuprina Holdings (cayman) LTD: too few analysts cover it.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY22 Q4 | $41.1K |
| FY23 Q4 | $75.1K |
| FY24 Q4 | $36.2K |
| FY25 Q4 | $38.2K |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Operating margin (TTM) |
|---|---|
| FY22 Q4 | -2077.4% |
| FY23 Q4 | -1060.1% |
| FY24 Q4 | -3404.9% |
| FY25 Q4 | -9680.2% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | FCF margin (TTM) |
|---|---|
| FY22 Q4 | -3296.4% |
| FY23 Q4 | -955.6% |
| FY24 Q4 | -2603.1% |
| FY25 Q4 | -18423.4% |
| Fiscal year | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|---|---|
| Income | ||||
| Revenue | 41 | 75 | 36 | 38 |
| Gross profit | 14 | 27 | −2 | −0 |
| EBITDA | −832 | −770 | −1,200 | −3,670 |
| Operating income | −853 | −796 | −1,231 | −3,698 |
| Net income | −794 | −834 | −1,168 | −3,578 |
| Diluted EPS | −$4.41 | −$4.63 | −$6.50 | −$17.48 |
| Growth (year on year) | ||||
| Revenue | — | +82.8% | −51.8% | +5.6% |
| Margins | ||||
| Gross margin | 35.3% | 36.3% | −6.3% | −1.3% |
| EBITDA margin | <−999% | <−999% | <−999% | <−999% |
| Operating margin | <−999% | <−999% | <−999% | <−999% |
| Net margin | <−999% | <−999% | <−999% | <−999% |
| Free-cash-flow margin | <−999% | −955.6% | <−999% | <−999% |
| Cash flow | ||||
| Cash from operations | −1,342 | −667 | −925 | −6,994 |
| Capital spending | 12 | 51 | 16 | 45 |
| Free cash flow | −1,354 | −717 | −942 | −7,038 |
| Balance sheet | ||||
| Cash | — | 27 | 85 | 2,425 |
| Total debt | — | 0 | 160 | 128 |
| Net debt (negative = net cash) | — | −27 | 75 | −2,296 |
| Diluted shares | 18m | 18m | 18m | 20m |
| Last 12 months unless stated | CUPR | POAS | PAVM | NXL | QTEX | HSCS | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $38204 | $102806 | $112000 | $217155 | $289000 | $4519 | $99m |
| Revenue growth, last 12 months | 5.6% | −18.2% | −89.0% | 24.2% | — | −64.2% | 9.2% |
| Revenue growth, 3-year average | — | — | −49.6% | −30.6% | — | — | 13.5% |
| Revenue growth, latest quarter | — | — | 450.0% | −82.8% | — | 10.5% | 10.2% |
| Gross margin | −1.3% | 13.1% | −220.5% | 86.2% | 0.7% | 60.9% | 61.2% |
| Operating margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | −8.5% |
| Operating margin, 3-year average | — | — | <−999% | <−999% | — | <−999% | −17.9% |
| Net margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | −12.0% |
| Cash from operations / revenue | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | −1.9% |
| Free-cash-flow margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | −3.9% |
| Free-cash-flow margin, 3-year average | — | — | <−999% | <−999% | — | — | −7.0% |
| Stock pay / revenue | — | — | >999% | >999% | >999% | >999% | 6.1% |
| Change in share count | 13.7% | 19.7% | 14.0% | 52.1% | 60.0% | 200.7% | 4.0% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 5.6% | 9.1% | 80 of 129 |
| Change in growth rate Growth | +57.4pp | -0.6pp | 3 of 129 |
| Gross margin Profitability | -1.3% | 61.9% | 120 of 123 |
| Operating margin Profitability | -9680.2% | -8.3% | 130 of 132 |
| Net margin Profitability | -9366.8% | -12.0% | 131 of 133 |
| Free-cash-flow margin Cash generation | -18423.4% | -3.4% | 128 of 128 |
| Long-term debt as % of assets Balance sheet | 1.5% | 24.2% | 12 of 87 |
| Change in share count Balance sheet | 13.7% | 3.3% | 88 of 115 |
| Days sales outstanding Balance sheet | 135 days | 57 days | 114 of 118 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | $53 | 0K | 100.0% | — |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Cuprina Holdings (cayman) LTD's complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
